In regard to EGFR/PTEN/mTOR-pathway alterations, the literature consistently reports mTOR to be active in cervical cancer and to be a key pathway modulating HPV-associated cell signaling alterations [10]. This evidence concerns the gene MTOR and cervical cancer.